Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 4 | 2023 | 1502 | 1.260 |
Why?
|
| Radiotherapy | 1 | 2021 | 18 | 0.800 |
Why?
|
| Mastectomy | 1 | 2021 | 15 | 0.800 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2021 | 37 | 0.800 |
Why?
|
| Weight Loss | 1 | 2021 | 131 | 0.740 |
Why?
|
| Weight Gain | 1 | 2021 | 136 | 0.730 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 182 | 0.700 |
Why?
|
| Neoadjuvant Therapy | 1 | 2023 | 13 | 0.220 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2023 | 20 | 0.220 |
Why?
|
| Neoplasms | 3 | 2021 | 1103 | 0.210 |
Why?
|
| Carcinoma, Ductal | 1 | 2021 | 4 | 0.200 |
Why?
|
| Receptor, erbB-2 | 1 | 2023 | 133 | 0.200 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 148 | 0.190 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 2379 | 0.190 |
Why?
|
| Genomics | 1 | 2022 | 223 | 0.190 |
Why?
|
| Female | 5 | 2023 | 20969 | 0.190 |
Why?
|
| Prognosis | 1 | 2021 | 739 | 0.170 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 974 | 0.160 |
Why?
|
| Humans | 8 | 2023 | 37093 | 0.160 |
Why?
|
| Mutation | 1 | 2022 | 1095 | 0.150 |
Why?
|
| Telemedicine | 1 | 2021 | 182 | 0.150 |
Why?
|
| Cohort Studies | 1 | 2021 | 1492 | 0.150 |
Why?
|
| Aged | 3 | 2021 | 6741 | 0.130 |
Why?
|
| Middle Aged | 3 | 2021 | 10129 | 0.110 |
Why?
|
| Adult | 3 | 2021 | 11712 | 0.100 |
Why?
|
| Small Molecule Libraries | 2 | 2010 | 45 | 0.100 |
Why?
|
| Thiadiazines | 1 | 2010 | 1 | 0.100 |
Why?
|
| Purine-Nucleoside Phosphorylase | 1 | 2010 | 2 | 0.100 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2010 | 113 | 0.090 |
Why?
|
| NADPH Dehydrogenase | 1 | 2009 | 11 | 0.090 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 206 | 0.080 |
Why?
|
| Actins | 1 | 2009 | 148 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2009 | 85 | 0.080 |
Why?
|
| p21-Activated Kinases | 1 | 2008 | 16 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 190 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 112 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2009 | 305 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 122 | 0.070 |
Why?
|
| Homeostasis | 1 | 2008 | 188 | 0.070 |
Why?
|
| Selection Bias | 1 | 2021 | 11 | 0.050 |
Why?
|
| Recurrence | 1 | 2021 | 131 | 0.050 |
Why?
|
| Survivors | 1 | 2021 | 136 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2021 | 138 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2021 | 534 | 0.040 |
Why?
|
| Perception | 1 | 2021 | 195 | 0.040 |
Why?
|
| Hawaii | 1 | 2021 | 1929 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2021 | 642 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2721 | 0.030 |
Why?
|
| United States | 1 | 2021 | 4223 | 0.020 |
Why?
|
| Methionine | 1 | 2010 | 30 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2010 | 83 | 0.020 |
Why?
|
| Fetal Proteins | 1 | 2009 | 3 | 0.020 |
Why?
|
| Pyrenes | 1 | 2009 | 25 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2009 | 69 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2009 | 130 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 269 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 408 | 0.020 |
Why?
|
| Naphthols | 1 | 2008 | 10 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2008 | 26 | 0.020 |
Why?
|
| Mice | 2 | 2009 | 5913 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2008 | 212 | 0.020 |
Why?
|
| Disulfides | 1 | 2008 | 77 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2008 | 161 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 307 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 444 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2008 | 389 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2008 | 272 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2010 | 1198 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 2231 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 803 | 0.010 |
Why?
|
| Male | 1 | 2021 | 20025 | 0.010 |
Why?
|
| Animals | 2 | 2009 | 15081 | 0.010 |
Why?
|